Immunogenicity & Bioassay Summit

This premier meeting offers unmatched opportunities to connect with regulatory leaders and scientific peers while exploring the latest advances in immunogenicity risk assessment, bioassay development, and clinical strategies.

With strong FDA representation, interactive discussions, and a vibrant exhibit and poster hall, the summit provides the insights and high-value networking opportunities you need to move your programs forward.

Visit us at Booth #5

Don't miss our presentation!

Track: Immunogenicity Prediction and Control
Date and time: Wednesday, October 21 – 2:50 PM
Speaker: Sofie Pattyn
Job Title: Chief Technology Officer
Title: Mind the gap: expanding immunogenicity assessment beyond HLA-DR and T cell centric approaches